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1. Introduction
The metabolism can be defined as the sum of all the biochemical reactions carried out by 
an organism. Metabolites are the intermediates and products of metabolism and are usually 
restricted to small molecules. The term “secondary” introduced by A. Kossel in 1891 implies 
that while primary metabolites are present in every living cell capable of dividing, the sec-
ondary metabolites are present only incidentally and are not of paramount significance for 
organism’s life. Though secondary metabolites are derived from primary metabolism, they 
do not make up basic molecular skeleton of the organism. Its absence does not immediately 
curtail the life of an organism, a feature contrary to primary metabolite, but survival of the 
organism is impaired to a larger extent. Its presence and synthesis are observed in ecologi-
cally disadvantaged species within a phylogenetic group [1].
The difference between primary and secondary metabolite is ambiguous since many of the 
intermediates in primary metabolism is overlapping with the intermediates of secondary 
metabolites [2]. Amino acids though considered a product of primary metabolite are definitely 
secondary metabolite too. Contrary to the observation that sterols are secondary metabolites 
that are indispensable part of many structural framework of a cell. The mosaic nature of an 
intermediate indicates common biochemical pathway being shared by primary and second-
ary metabolism [3]. The secondary metabolites serve as a buffering zone into which excess C 
and N can be shunted into to form inactive part of primary metabolism. The stored C and N 
can revert back to primary metabolite by the metabolic disintegration of secondary metabolite 
when on demand. There is dynamism and a delicate balance between the activities of the pri-
mary and secondary metabolism (Figure 1) being influenced by growth, tissue differentiation 
and development of the cell or body, and also external pressures [4].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Hence, secondary metabolites or natural products can be defined as a heterogeneous group 
of natural metabolic products that are not essential for vegetative growth of the producing 
organisms, but they are considered differentiation compounds conferring adaptive roles, for 
example, by functioning as defense compounds or signaling molecules in ecological interac-
tions, symbiosis, metal transport, competition, and so on [5]. The multitude of secondary 
metabolite secretions is harvested by human kind to improve their health (antibiotics, enzyme 
inhibitors, immunomodulators, antitumor agents, and growth promoters of animals and 
plants), widen the pyramid of healthy nutrition (pigments and nutraceuticals), enhancing 
agricultural productivity (pesticides, insecticides, effectors of ecological competition and 
symbiosis and pheromones), and hence impacting economics our society in a certain positive 
way. They are a source of antibiotics.
2. Classification of secondary metabolites
Over 2,140,000 secondary metabolites are known and are commonly classified according to 
their vast diversity in structure, function, and biosynthesis. There are five main classes of 
secondary metabolites such as terpenoids and steroids, fatty acid-derived substances and 
polyketides, alkaloids, nonribosomal polypeptides, and enzyme cofactors [6].
2.1. Terpenoids and steroids
They are major group of substances derived biosynthetically from isopentenyl diphosphate. 
Currently, over 35,000 known terpenoid and steroid compounds are identified. Terpenoids 
Figure 1. Schematic diagram representing integration of primary and secondary metabolism.
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have different variety of unrelated structures, while steroids have a common tetracyclic carbon 
skeleton and are modified terpenoids that are biosynthesized from the triterpene lanosterol.
2.2. Alkaloids
There are over 12,000 known compounds of alkaloids, and their basic structures consist of 
basic amine group and are derived biosynthetically from amino acids.
2.3. Fatty acid-derived substances and polyketides
Around 10,000 compounds are identified and are biosynthesized from simple acyl precursors 
such as propionyl CoA, acetyl CoA, and methylmalonyl CoA.
2.4. Nonribosomal polypeptides
These amino acids derived compounds are biologically synthesized by a multifunctional 
enzyme complex without direct RNA transcription.
2.5. Enzyme cofactors
Enzyme cofactors are nonprotein, low-molecular enzyme component [6].
3. Functions of secondary metabolites
The major functions of the secondary metabolites including antibiotics are:
(i) competitive weapons against other livings such as animals, plants, insects, and 
microorganisms
(ii) metal transporting agents
(iii) agents for symbiotic relation with other organisms
(iv) reproductive agent and
(v) differentiation effectors
(vi) agents of communication between organisms
The other functions include interference in spore formation (not obligatory) and germination 
[5]. Predominantly, the secondary metabolites are used for variety of biological activities like 
antimicrobial and antiparasitic agents, enzyme inhibitors and antitumor agent, immunosup-
pressive agents, etc. [7].
4. Sources of secondary metabolites
The major sources of secondary metabolites are plants (80% of secondary metabolite), bacte-
ria, fungi, and many marine organisms (sponges, tunicates, corals, and snails) (Table 1) [8].
An Introductory Chapter: Secondary Metabolites
http://dx.doi.org/10.5772/intechopen.79766
5
4.1. Secondary metabolites of plants
Plant secondary metabolites represent highly economically valuable products. These are used 
as high value chemicals such as drugs, flavors, fragrances, insecticides, dyes, etc. Plants are 
rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and 
flavonoids, which have been found to have in vitro antimicrobial properties. Plants have an 
almost limitless ability to synthesize aromatic substances, most of which are phenols or their 
oxygen-substituted derivatives [9]. About 25,000 terpenoids are known as secondary com-
pounds and are derived from the five-carbon precursor isopentenyl diphosphate (IPP). In 
total, around 12,000 known alkaloids are identified, and they possess one or more nitrogen 
atoms which are biosynthesized from amino acids. The 8000 known phenolic compounds 
are synthesized either through the shikimic acid pathway or through the malonate/acetate 
pathway [10].
Many alkaloids are used in medicine, usually in the form of salts. Some examples include 
vinblastine which has antitumor properties [11]; quinine which has antipyretics and antima-
larial properties [12]; and reserpine which can be used to treat high blood pressure. Alkaloids 
are regarded as reserve materials for protein synthesis, as protective substances discouraging 
animal or insect attacks, and as plant stimulants or regulators or simply as detoxification 
products. Alkaloids currently in clinical use include the analgesics morphine and codeine, the 
anticancer agent vinblastine, the gout suppressant colchicine, the muscle relaxant tubocura-
rine, the antiarrhythmic ajmalicine, the antibiotic sanguinarine, and the sedative scopolamine.
In vitro studies have shown that natural phenols have antimicrobial [13], antiviral [14], anti-
inflammatory [15], and vasodilatory actions [16]. It protects the plant against adverse factors 
Source All known 
compounds
Bioactives Antibiotics
Natural products Over one million 200,000–250,000 25,000–30,000
Plant kingdom 600,000–700,000 150,000–200,000 ~25,000
Microbes Over 50,000 22,000–23,000 ~17,000
Algae, lichens 3000–5000 1500–2000 ~1000
Higher plants 500,000–600,000 ~100,000 10,000–12,000
Animal kingdom 300,000–400,000 50,000–100,000 ~5000
Protozoa Several hundreds 100–200 ~50
Invertebrates ~100,000 NA ~500
Marine animals 20,000–25,000 7000–8000 3000–4000
Insects/ worms/ etc. 8000–10,000 800–1000 150–200
Vertebrates (mammals, fishes, amphibians, etc.) 200,000–250,000 50,000–70,000 ~1000
NA – Data Not Available.
Source: Bérdy [8].
Table 1. Approximate number of known natural metabolites.
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which threaten its survival in an unfavorable environment, such as drought, physical damage 
or infections. Resistance of plants to UV radiations is due to the phenolic compounds espe-
cially the phenylpropanoids present in them [17]. Phenolic compounds act as antioxidants 
protecting cells from oxidative stress scavenging of free radicals by hydrogen atom donation. 
The action of phenolic as neuroprotective [18], fungicidal [19], bactericidal [20] compounds 
and their anti-atherosclerosis [21] effects, and anticancer [22] activity is well documented.
Terpenoids are commercially important fragrance and flavoring agents [23]. Prenol and 
α-bisabolol are used in fragrance due to fruity odor and sweet floral aroma, respectively. 
Mono and sesqui terpenes are basis of natural perfumes and also of spices and flavorings in 
the food industry. The roles of terpenoids as pharmaceutical agents with activities such as 
antibacterial and antineoplastic are still under investigation. There are examples of diterpenes 
that exhibited in vitro cytotoxic, antitumor, and antimicrobial activities. Terpenes are vital for 
life in most organisms exerting metabolic control and mediating inter and intra species inter-
actions, for example, manufacture compounds in response to herbivory or stress factors, and 
it has also been shown that flowers can emit terpenoids to attract pollinating insects and even 
attract beneficial mites, which feed on herbivorous insects. Cheng et al. [24] have reported 
that terpenes may act as chemical messengers influencing the expression of genes involved in 
plant defensive functions or influence gene expression of neighboring plants. Other second-
ary metabolite of plant origin and their functions is given in Table 2 [25].
4.2. Production of secondary metabolites from plants
4.2.1. Conventional
The conventional method of secondary metabolite production relies on extraction of metabo-
lite, not production, from the tissues of plant by different phytochemical procedures like 
solvent, steam, and supercritical extraction. The recent developments in biotechnological 
methods like plant tissue culture, enzyme and fermentation technology have facilitated 
in vitro synthesis and production of plant secondary metabolites. The major processes include:
4.2.2. Immobilization
Cell or biocatalysts are confined within a matrix by entrapment, adsorption or covalent 
linkage. On addition of suitable substrate and provision on optimum physico chemical 
parameters, the desired secondary metabolites are synthesized. Immobilization with suitable 
bioreactor system provides several advantages, such as continuous process operation, but for 
the development of an immobilized plant cell culture process, natural or artificially induced 
secretion of the accumulated product into the surrounding medium is necessary.
4.2.3. In vitro tissue, organ, and cell culture
Plant cell and tissue cultures can be established routinely under sterile conditions from 
explants, such as plant leaves, stems, roots, meristems, etc., both for multiplication and extrac-
tion of secondary metabolites. Shoot, root, callus, cell suspension, and hairy root culture are 
used to synthesize metabolite of interest. Metabolites which are localized in multiple tissues 
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S. No. Secondary metabolites Biological activity
1. Pyrethrins Insecticidal
2. Nicotine Insecticidal
3. Rotenoids Insecticidal
4. Azadirachtin Insecticidal
5. Phytoecdysones Insecticidal
6. Baccharine Antineoplastic
7. Bruceantine Antineoplastic
8. Gsaline Antineoplastic
9. 3-Doxycolchicine Antineoplastic
10. Ellipticine Antineoplastic
11. 9-methoxyellipticine Antineoplastic
12. Fagaronive Antineoplastic
13. Tlarringtovinl Antineoplastic
14. Jandicine N-oxide Antineoplastic
15. Maytansive Antineoplastic
16. Podophyllotoxin Antineoplastic
17. Taxol Antineoplastic
18. Thalicarpine Antineoplastic
19. Tripdiolide Antineoplastic
20. Vinblastin Antineoplastic
21. Quinine Antimalarial
22. Digoxin Cardiac tonic
23. Diosgunin Antifertility
24. Morphine Analgesic
25. Thebaine Source of codeine
26. Suolpolanine Antihypertension
27. Alropine Muscle relaxant
28. Codeine Analgesic
29. Shikonin Dye, pharmaceutical
30. Anthroquinones Dye, laxative
31. Rosamarinic acid Spice, antioxidant, perfume
32. Jasmini Sweetner
33. Stevioside Saffron
34. Croun Chili
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can be synthesized through unorganized callus or suspension cultures. But when the metabo-
lite of interest is restricted to specialized part or glands in host plant, differentiated microplant 
or organ culture is the method of choice. Saponins from ginseng are produced in its roots, 
and hence in vitro root culture is preferred for saponin synthesis. Similarly, antidepressant 
hypericin and hyperforin are localized in foliar glands of Hypericum perforatum, which have 
not been synthesized from undifferentiated cells [26].
The quantum of secondary metabolite production in cell cultures can be enhanced by treating 
plant cells with biotic and/or abiotic elicitors. Methyl jasmonate, fungal carbohydrates, and 
yeast extract are the commonly used elicitors. Methyl jasmonate is an established and effec-
tive elicitor used in the production of taxol from Taxus chinensis [27] and ginsenoside from 
Panax ginseng [28–32]. The most recently evolved and designed metabolic engineering can be 
employed to improve the productivity.
The production of metabolites through hairy root system based on inoculation with Agrobacte rium 
rhizogenes has garnered much attention of late. The quality and quantity of secondary metabolite 
by hairy root systems is same or even better than the synthesis by intact host plant root [33]. 
In addition, stable genetic make up, instant growth in plant tissue culture media san phytohor-
mones provides additional scope for biochemical studies. Root tips infected with A. rhizogenes are 
grown on tissue culture media [Murashige and Skoog’s (MS) Gamborg’s B5 or SH media] lacking 
phytohormones. Srivastava and Srivastava [34] have recently summarized the attempts to adapt 
bioreactor design to hairy root cultures; stirred tank, airlift, bubble columns, connective flow, tur-
bine blade, rotating drum, as well as different gas phase reactors have all been used successfully. 
Genetic manipulation in hairy root culture for secondary metabolite production is being tried out. 
The established roots are screened for higher growth and production of metabolites. Transgenic 
hairy roots generated though Agrobacterium rhizogenes have not only paved way for plantlet gen-
eration but also for synthesis of desired product through transgenic hairy root cultures.
S. No. Secondary metabolites Biological activity
35. Capsacin Vanilla
36. Vanillin Rubber
37. Gutla percha Essential oils
38. Terpendids Spasmolytic
39. Papaverive Hypertensive
40. Ajmalicive Stimulant
41. Caffeine Antispasmadic
42. Birberine NA
NA – Not Assessed.
Source: Ramawat and Merillon [25].
Table 2. Biological activities of some secondary metabolites of plants.
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4.3. Secondary metabolites of microorganisms
Microbial secondary metabolites are low molecular mass products with unusual structures. 
The structurally diverse metabolites show a variety of biological activities like antimicrobial 
agents, inhibitors of enzymes and antitumors, immune-suppressives and antiparasitic agents 
[7], plant growth stimulators, herbicides, insecticides, antihelmintics, etc. They are produced 
during the late growth phase of the microorganisms. The secondary metabolite production is 
controlled by special regulatory mechanisms in microorganisms, as their production is gener-
ally repressed in logarithmic phase and depressed in stationary growth phases. The microbial 
secondary metabolites have distinctive molecular skeleton which is not found in the chemical 
libraries and about 40% of the microbial metabolites cannot be chemically synthesized [35].
4.3.1. Features of microbial secondary metabolites
• The principle and process of natural fermentation product synthesis can be successfully 
scaled up and employed to maximize its application in the field of medicine, agriculture, 
food, and environment.
• The metabolite can serve as a starting material for deriving a product of interest, extended 
further through chemical or biological transformation.
• New analog or templates in which secondary metabolite serve as lead compounds will lead 
discovery and design of new drugs.
4.4. Applications of microbial secondary metabolites
4.4.1. Antibiotics
The discovery of penicillin initiated the researchers for the exploitation of microorganisms for 
secondary metabolite production, which revolutionized the field of microbiology [5]. With the 
advent of new screening and isolation techniques, a variety of β-lactam-containing molecules 
[36] and other types of antibiotics have been identified. About 6000 antibiotics have been 
described, 4000 from actinobacteria (Table 3). In the prokaryotic group, unicellular bacteria 
Bacillus (Table 3) and Pseudomonas (Table 3) species are the most recurrent antibiotic produc-
ers. Likewise in eukaryotes, fungi are dominant antibiotic producers next to plants (Table 3). 
In the recent years, myxobacteria and cyanobacteria species have joined these distinguished 
organisms as productive species.
The pharmaceutical product, especially anti-infective derivatives comprise 62% antibacteri-
als, 13% sera, immunoglobulins, and vaccines, 12% anti-HIV antivirals, 7% antifungals, and 
6% nonHIV antivirals. There are over 160 antibiotics. Streptomyces hygroscopicus with over 
200 antibiotics, Streptomyces griseus with 40 antibiotics, and Bacillus subtilis with over 60 com-
pounds are the major contributors to the antibiotic market [7].
4.4.2. Antitumor agents
Natural product and its derivatives account for more than 60% of anticancer formula-
tions. Actinobacteria derived antineoplastic molecules currently in use are actinomycin D, 
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Name of secondary metabolites Source of secondary 
metabolites
Biological activities References
Secondary metabolites of Actinobacteria
Resistomycin S. corchorusii HIV-1 protease inhibitor Shiono et al. [39]
Himalomycins A and B Streptomyces sp. B6921 Antimicrobial Maskey et al. [40]
Bonactin Streptomyces sp. BD21–2 Antibacterial Schumacher et al. [41]
Trioxacarcins S. ochraceus and S. 
bottropensis
Antitumor and antimalarial Maskey et al. [42]
Chinikomycins A and B Streptomyces sp. Antitumor and antiviral Li et al. [43]
Daryamides Streptomyces sp. CNQ-085 Cytotoxic polyketides Asolkar et al. [44]
Resistoflavine S. chibaensis Antibacterial Gorajana et al. [45]
Chalcomycin A and terpenes Streptomyces sp. M491 Antibacterial Wu et al. [46]
Napyradiomycin (C-16 
stereoisomers)
S. antimycoticus Antibacterial Motohashi et al. [47]
Oxohexaene and Cephalaxine Streptomyces sp. RM17; 
Streptomyces sp. RM42
Antibacterial Remya and 
Vijayakumar [48]
Citreamicin θ A, Citreamicin θ B, 
and Citreaglycon A
S. caelestis Antibacterial Liu et al. [49]
Spiramycin Streptomyces sp. RMS6 Antibacterial Vijayakumar and 
Malathi [50]
N-isopentyltridecanamide Streptomyces labedae ECR 
77
Antibacterial Thirumurugan et al. 
[51]
Staurosporine Streptomyces champavatii 
KV2
Antimicrobial Cholarajan and 
Vijayakumar [52]
Secondary metabolites of Bacillus spp.
Coagulin B. coagulans Bactericidal, Bacteriolytic Le Marrec et al. [53]
Bacthurucin f4 B. thuringenesis sp. Fungicidal sub sp., kurstaki 
BUPM4
Kamoun et al. [54]
Cerein B. cereus Bactericidal, bacteriolytic Bizani et al. [55]
Megacin B. megaterium , Lisboa et al. [56]
Thuricin S B. thuringenesis , Chehimi et al. [57]
Thuricin CD 19 B. thuringenesis DPC6431
B. anthracis
, Rea et al. [58]
Halobacillin 5b B. licheniformis Hemolytic, cytotoxic Kalinovskaya et al. 
[59]
Bacillomycin B. amyloliquefacins FZB42,
B. subtilis
Antifungal hemolytic Ramarathnam et al. 
[60]
Bacilysocin B. subtilis Fungicidal, antibacterial Tamehiro et al. [61]
Bacilysin 1 B. subtilis 168, B. pumilus
B. amyloliquefaciens 
GSB272
Antifungal, antibacterial Steinborn et al. [62]
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anthracyclines (daunorubicin, doxorubicin, epirubicin, pirarubicin, and valrubicin), bleomy-
cin, mitosanes (mitomycin C), anthracenones (mithramycin, streptozotocin, and pentostatin), 
enediynes (calicheamicin), taxol, and epothilones [37].
Taxol is the nonactinobacterial molecule derived from plant Taxus brevifolia and endophytic 
fungi Taxomyces andreanae and Nodulisporium sylviforme. It interferes with microtubule break-
down, an essential event leading to cell division, thereby inhibiting rapidly dividing cancer 
cells. It is effective against breast and advanced form Kaposi’s sarcoma. It is also found to 
exhibit antifungal activity against Pythium, Phytophthora, and Aphanomyces.
4.4.3. Pharmacological and nutraceutical agents
One huge success was the discovery of the fungal statins, including compactin, lovastatin, 
pravastatin, and others which act as cholesterol-lowering agents. Lovastatin is produced by A. 
terreus. Of great importance in human medicine are the immunosuppressants such as cyclo-
sporin A, sirolimus (rapamycin), tacrolimus, and mycophenolate mofetil. They are used for 
heart, liver, and kidney transplants and were responsible for the establishment of the organ 
transplant field. Cyclosporin A is made by the fungus Tolypocladium niveum. Mycophenolate 
mofetil is a semisynthetic product of the oldest known antibiotic, mycophenolic acid, and 
is also made by a fungus. Sirolimus and tacrolimus are products of streptomycetes [7]. 
Metabolites of probiotic bacteria are considered as a remedy for controlling weight gain, pre-
venting obesity, increasing satiety, prolonging satiation, reducing food intake, reducing fat 
deposition, improving energy metabolism, treating and enhancing insulin sensitivity, and 
Name of secondary metabolites Source of secondary 
metabolites
Biological activities References
Secondary metabolites of Pseudomonas spp.
Pseudomonine P. stutzeri KC Competitive inhibition of 
phytopathogens
Lewis et al. [63]
Hydrogen cyanide P. pseudoalcaligenes P4 Antifungal Ayyadurai et al. [64]
Secondary metabolites of Fungi
Lovastatin Monascus ruber;
Aspergillus terreus
Enzyme inhibitor Dewick [65]
Limonene and guaiol Trichoderma viride Antimicrobial Awad et al. [66]
Tuberculariols Tubercularia sp. TF5 Anticancer Xu et al. [67]
Oxaline Penicillium raistricki Anti-cell proliferation Sumarah et al. [68]
Benzomalvin C Penicillium raistrickii, 
Penicillium sp. SC67
Antimalarial Stierle et al. [69]
Roquefortine C P. roqueforti; P. crustosum Neurotoxin Kim et al. [70]; Xu 
et al. [67]
Pravastatin Penicillium citrinum Anticholesterolemics Gonzalez et al. [71]
Table 3. Secondary metabolites produced by microorganisms.
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treating obesity. Firmicutes and Bacteroidetes are the dominant beneficial bacteria present in 
the normal human gastrointestinal tract, and the latter was reported in lower numbers in 
constipation-predominant irritable bowel syndrome patients [38]. Carotenoids of microbial 
origin are used as food colorant, fish feeds, nutraceuticals, cosmetics, and antioxidants. Food 
colorant widely used is carotene derived from Blakeslea trispora, Dunaliella salina and lycopene 
from B. trispora and Streptomyces chrestomyceticus, subsp. rubescens. Astaxanthin produced 
from Xanthophyllomyces dendrorhous is an approved fish feed. Astaxanthin, lutein, β-carotene, 
zeaxanthin, and canthaxanthin are used as nutraceuticals due to their excellent antioxidant 
property. Docosahexaenoic acid (DHA) used in infant formula as nutritional supplements is 
derived from microalgae Schizochytrium spp. [7].
4.4.4. Enzymes and enzyme inhibitors
Enzymes produced from microorganism have annual sales of US $ 2.3 billion enzymes that 
find application in detergents (34%), foods (27%), agriculture and feeds (16%), textiles (10%), 
and leather, chemicals, and pulp and paper (10%). The protease subtilisin used in detergents 
has an annual sale of $ 200 million. The other major enzymes include glucose isomerase 
(100,000 tons) and penicillin amidase (60,000 tons). Nitrilase (30,000 tons) and phytase are 
amounting for $135 million worth of production. Streptomyces glucose isomerase is used to 
isomerize D-glucose to D-fructose, to make 15 million tons per year of high fructose corn 
syrup, valued at $1 billion [7].
The most important enzyme inhibitors are clavulanic acid, synthesized by Streptomyces cla-
vuligerus, the inhibitor of β-lactamases. Some of the common targets for other inhibitors are 
glucosidases, amylases, lipases, proteases, and xanthine oxidase. Amylase inhibitors prevent 
absorption of dietary starches into the body, and hence can be used for weight loss [38].
4.4.5. Agricultural and animal health products
Secondary metabolites find wide applications in the field of agriculture and animal health: 
kasugamycin and polyoxins are used as biopesticides; Bacillus thuringiensis crystals, nikkomy-
cin, and spinosyns are used as bioinsecticides; bioherbicides (bialaphos) find application as 
bioherbicides; ivermectin and doramectin as antihelmintics and endectocides against worms, 
lice, ticks, and mites; ruminant growth promoters in the form of coccidiostats; plant hormones 
like gibberellins as growth regulators are the most common application [7].
4.5. Production of secondary metabolites from microorganisms
Secondary metabolites branch out from the pathways of primary metabolism. Commercially, 
important secondary and primary metabolic pathways are given in Table 4.
4.5.1. Liquid fermentation
Batch or fed-batch culture in submerged fermentation is employed for production of second-
ary metabolites. Inoculum is developed after careful strain improvement of producing organ-
ism. Initially, shake flasks culture is employed, and the culture which are in active growth 
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phase are transferred to a small fermenter and later into a larger fermenter with production 
medium. Several parameters, like medium composition, pH, temperature, and agitation and 
aeration rate, are controlled. An inducer such as methionine is added to cephalosporin fer-
mentations, phosphate is restricted in chlortetracycline fermentation, and glucose is avoided 
in penicillin or erythromycin fermentation.
4.5.2. Solid-state fermentation
Solid-state fermentation, defined as a microbial culture that develops on the surface and at the 
interior of a solid matrix and in the absence of free water, holds an important potential for the 
production of secondary metabolites. Two types of SSF can be distinguished, depending on 
Figure 2. Chemical structures of actinobacterial secondary metabolites. (a) Staurosporine, (b) octa-valinomycin, (c) 
methyl-4,8-dimethylundecanate, and (d) N-isopentyltridecanamide from actinobacteria. Source: Cholarajan and 
Vijayakumar [52]; Cholarajan [72]; Thirumurugan et al. [73].
S. No. Intermediates from primary 
metabolic pathway
Secondary metabolites derived
1. Shikimic acid Ergot alkaloids, antibiotics: candicidin and chloramphenicol
2. Amino acids Antibiotics: penicillin, cephalosporins and cephamycins, and 
gramicidin, immunosuppressive cyclosporine
3. Acetyl-CoA and other Kreb’s cycle 
intermediates
Antibiotics: erythromycin, antiparasitic avermectin antitumor 
doxorubicin, taxol
4. Sugars Antibiotics: streptomycin and kanamycin.
Table 4. Intermediate from primary metabolism and their secondary metabolite derivatives.
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the nature of solid phase used [7]: (a) solid culture of one support-substrate phase solid phase 
and (b) solid culture of two substrate-support phase solid phase. The advantages of solid-
state fermentation in relation with submerged fermentation include: energy requirements 
of the process are relatively low, since oxygen is transferred directly to the microorganism. 
Secondary metabolites are often produced in much higher yields, often in shorter times, and 
often sterile conditions are not required [7].
It is important here to note our own experience of deriving actinobacterial secondary metabo-
lite. Actinobacteria from terrestrial and marine habitats were screened for their antimicrobial 
activity. The bioactive metabolites were extracted and purified by thin layer and column chro-
matography, and the structure of the metabolite was elucidated by UV-spectrometry, FT-IR, 
mass spectrum analysis, and NMR. The derived metabolites staurosporine, octa-valinomycin, 
methyl-4,8-dimethylundecanate, and N-isopentyltridecanamide are known for their biologi-
cal activity (Figure 2).
5. Conclusion
This review emphasizes the importance of secondary metabolites from various sources like 
plants, microorganisms including bacteria, actinobacteria, and fungi and its classification, 
production and applications in various fields. Since there is a constant and crucial require-
ment for new pharmaceutical agents to fight cancers, cardiac disorders, pests, cytotoxic, mos-
quitoes, infectious diseases, and autoimmune disorders of both animals and plants as climate 
changes provide conditions favorable to repeated outbreaks of these events. The battle against 
any disease is a vibrant symmetry between advances in chemotherapy and natural selection 
on infectious or invasive agents. If the scientific community is to put constant importance 
in this never ending effort, then new sources of bioactive secondary metabolites with novel 
activities must be found. Secondary metabolites are one of their essential means of growth 
and defense, and these metabolites are readily available for discovery. Secondary metabolites 
with noteworthy biological activity are considered as an alternative to most of the synthetic 
drugs and other commercially valuable compounds.
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